维普期刊资源整合服务平台（V6.5）

63篇 您的检索式：作者名="VanderLugt"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	CTLA4:a negative regulator of autoimmune disease显示文摘	Karandikar NJ Vanderlugt CL Walunas TL	1996	J Exp Med1996，184，：	1
2	CTLA4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis显示文摘	Karandikar N Eagar N Vanderlugt L	2000	J Neuroimmunol2000，109，2：	1
3	Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery 显示文摘	Vanderlugt JT Mattioni T Denker S	1999	Circulation1999，100，4：	1
4	Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/ flutter 显示文摘	Kowey PR Vanderlugt JT Luderer JR	1996	Am J Cardiol1996，78，8：	1
5	Epitope spreading in inanune-mediated diseases: implications for inanunotherapy 显示文摘	Vanderlugt CL Miller SD	2002	Nat Rev Ineramol2002，2，2：	1
6	Discordant effects of anti-VLA4 treatment before and after onset of relapsing experimental auto immune encephalomyelitis 显示文摘	Theien BE Vanderlugt CL Eagar TN	2001	J Clin Invest2001，107，：	1
7	Signal detection by complex matched spatial filtering显示文摘	Vanderlugt A B	1964	IEEE Transactions on Inf Theory1964，10，：	1
8	Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter显示文摘	KOWEY PR VANDERLUGT JT LUDERER JR	1996	Am J Cardiol1996，78，8：	1
9	Effects of ibutilide fumarate,a new class Ⅲ antiarrhythmic agent in man显示文摘	Vanderlugt JT Gaylor SK Wakefield LK	1991	Clin Pharmacol Ther1991，49，：	1
10	Epitope spreading in immune-mediated disease: implications for immunotherapy显示文摘	Carol L Vanderlugt Stephen D	2002	Nature Rev Immunol2002，2，：	1
11	Safety and risk/benefit annlysis of ibutilide for acute conversion of atrial fibrillation/flut- ter显示文摘	Kowey PR VanderLugt JT Luderer JR	1996	Am J Cardiol1996，78，：	1
12	Treatment of Established Relapsing Experimental Autoimmune Encephalomyelitis with the Proteasome Inhibitor PS-519 显示文摘	Vanderlugt C L Rahbe S M Elliott P J	2000	Autoimmun2000，14，3：	1
13	The pharmaeokineties (PK) and pharmoeodynamies (PD) of ibutilide fumarate (IBUT) after intravenous infusions in healthy volunteers 显示文摘	JUNGBLUTH GL VANDERLUGT JT KABELL GG	1990	Pharm Res1990，79，：	1
14	Evaluation of the pharmacokinetics and pharmocodynamics of ibutilide fumarate and its enantiomers in healthy male volunteers显示文摘	JUNGBLUTH GL DELLA-COLETTA AA VANDERLUGT JT	1991	Pharm Res1991，810，：	1
15	CTLA4:A negative regulator of autoimmune disease显示文摘	Karandikar NJ Vanderlugt CL Walunas TL	1996	J Exp Med1996，184，2：	1
16	Posteriortransformation,neurological,abnormalities,and severe hematopoietic defects in mice with a targeted deletion of the Bmi-1 protooncogene显示文摘	Vanderlugt NM Domen J Linders K	1994	Genes Dev1994，，8：	1
17	Signal Detection by Complex Filter显示文摘	VanderLugt A	1964	IEEE Trans on Inf Theory1964，10，1：	1
18	Blockade of CD28/B7-l interaction prevents epitope spreading and clinical relapses of murine EAE显示文摘	Miller SD Vanderlugt CL Bluestone JA	1995	Immunity1995，3，：	1
19	Epitope spreading显示文摘	Carol J Vanderlugt Stephen D Miller	1996	Current Opinion in Immunology1996，，6：	1
20	Safety and risk/benefit of ibutilide for acute conversion of atrial fibrillation/flutter显示文摘	Kowey PR Vanderlugt J Luderer JR	1996	Am J Cardiaol1996，78，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示